GLP-1, leptin, ghrelin, and CCK directly modulate taste receptor expression and function on the tongue, creating a gut-brain-taste axis that links metabolic state to flavor perception and food choices.
Direct taste receptor modulation confirmedGLP-1 and other gut peptide hormones don't just suppress appetite — they actually change how taste buds on the tongue detect and respond to flavors
What the researchers found
Gut peptide hormones directly influence taste perception through multiple mechanisms: they regulate taste receptor expression and function in taste buds and the gastrointestinal tract. GLP-1, leptin, ghrelin, and CCK each modulate specific aspects of taste sensitivity at both peripheral (tongue) and central (brain reward circuitry) levels. Metabolic conditions like obesity and diabetes — characterized by hormonal resistance (leptin, insulin) and neurotransmitter dysregulation — contribute to altered taste preferences and compulsive eating behaviors. The review establishes a gut-brain-taste axis integrating peripheral gustatory signals with central homeostatic and hedonic mechanisms.
Why it matters
Understanding why GLP-1 drugs change taste perception helps explain one of the most commonly reported but poorly understood effects of these medications. If GLP-1 directly modifies taste bud function, this could be both a therapeutic mechanism (reducing desire for unhealthy foods) and a side effect concern (reducing food enjoyment). The gut-brain-taste axis concept also opens new therapeutic targets — designing drugs that specifically modify taste preferences could complement appetite-suppressing medications.
How the study worked
Narrative review synthesizing evidence on how peptide hormones and neuromodulators influence taste receptor biology, gustatory signaling, and feeding behavior. Covers molecular, cellular, and systems-level evidence from animal and human studies.
What this study cannot tell us
This is a narrative review without systematic methodology. Much of the evidence for direct taste receptor modulation by peptide hormones comes from animal studies and may not translate quantitatively to humans. The mechanisms linking metabolic conditions to taste changes are still being elucidated and may be more complex than presented. Individual variation in taste perception changes with GLP-1 drugs is not addressed.
How to read the evidence
This is a narrative review synthesizing molecular, cellular, and behavioral evidence from multiple research groups. While the conceptual framework is well-supported, much of the evidence for specific taste receptor modulation comes from animal models.
When this study was published
Published in 2025, this review is timely given the millions of patients currently on GLP-1 drugs reporting taste changes and food aversions.
The bigger picture
Patients on GLP-1 drugs frequently report food aversion, altered taste, and reduced enjoyment of previously favorite foods. This review provides the biological basis for these experiences — it's not just about reduced appetite, it's about fundamentally changed taste perception. As millions of people take GLP-1 drugs, understanding these taste effects becomes clinically important. The broader implication is that the endocrine system actively shapes what we perceive as 'delicious,' linking metabolic health directly to food preferences.
Questions still open
- Could taste receptor modulation be deliberately targeted to reduce cravings for unhealthy foods without affecting overall appetite?
- Do the taste changes reported by GLP-1 drug users normalize after treatment discontinuation?
- Are some patients' food aversions on GLP-1 drugs driven more by peripheral taste receptor changes than by central appetite suppression?
Common questions
Why does food taste different when you're on GLP-1 drugs like Ozempic?
Does your metabolic health really affect how food tastes?
Read the original research
Potential role of glucagon like peptide 1 in taste receptors.
Frontiers in endocrinology, 16, 1683419
Citation
Doval-Caballero, Jose Luis Eduardo; Ferreira-Hermosillo, Aldo; Eugenio-Ponce, Genesis Dinora; García-Sáenz, Manuel Ramon; Ibarra-Salce, Raúl; Tenorio-Rojo, Andrea Patricia; Luna-Avila, Eduardo Salif; Gete-Palacios, Paulo César; Pérez-Hernández, Fernando; Rojas-Milán, Eduardo; López-Cruz, Luis Angel; Méndez-Hernández, César Alejandro. (2025). Potential role of glucagon like peptide 1 in taste receptors.. Frontiers in endocrinology, 16, 1683419. https://doi.org/10.3389/fendo.2025.1683419